Solventum Corporation (SOLV)
NYSE · Healthcare
Solventum Corporation Income Statement 2022–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | |
|---|---|---|---|---|
| Revenues | ||||
| Revenue | 8.32B | 8.25B | 8.20B | 8.13B |
| Gross Profit | 4.45B | 4.59B | 4.69B | 4.70B |
| Profitability | ||||
| Operating Income | 2.18B | 1.04B | 1.69B | 1.69B |
| EBITDA | 2.67B | 1.59B | 2.25B | 2.27B |
| Net Income | 1.56B | 479.0M | 1.35B | 1.34B |
| Per Share Data | ||||
| EPS (diluted) | — | — | — | — |
| Shares Outstanding (dil.) | 175M | 174M | 173M | 173M |
Solventum Corporation Income Statement — FAQ
Solventum Corporation (SOLV) income statement over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see SOLV's income statement history?
The chart and table above show Solventum Corporation's income statement by year and by quarter, including the growth rate.